Specific analysis of KIT and PDGFR‐alpha expression and mutational status in Merkel cell carcinoma
- 29 April 2013
- journal article
- clinical trial
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 40 (7) , 623-630
Abstract
Background: The purpose of this study was to explore the immunohistochemical and mutational status of the tyrosine kinases KIT and platelet derived growth receptor‐alpha (PDGFRA) in Merkel cell carcinoma (MCC). Specifically, we examined the mutated exons in gastrointestinal stromal cell tumors that may confer a treatment response to imatinib mesylate.Methods: We evaluated KIT and PDGFRA immunostaining in 23 examples of MCC utilizing laser capture microdissection to obtain pure samples of tumor genomic DNA from 18 of 23 examples of MCC. PCR amplification and sequencing of KIT exons 9, 11, 13 and 17, and PDGFRA exons 10, 12, 14 and 18 for mutations was performed.Results: Fifteen of 23 tumors (65%) demonstrated CD117 expression and 22 of 23 tumors (95%) demonstrated PDGFRA expression. A single heterozygous KIT exon 11 base change resulting in an E583K mutation was discovered in 12 of 18 (66%) examples of MCC. In addition, a single nucleotide polymorphism was detected in eight of 18 tumors (44%) in exon 18 of PDGFRA (codon 824; GTC > GTT).Conclusions: We discovered a novel somatic KIT exon 11 E583K mutation in 66% of tumors. This mutation has been previously described in a human with piebaldism and appears to represent an inactivating mutation. Therefore, despite expression of CD117 and PDGFRA, the absence of activating mutations in these tyrosine kinases makes KIT and PDGFRA unlikely candidates of MCC oncogenesis.Keywords
This publication has 39 references indexed in Scilit:
- Association of Merkel cell polyomavirus infection with tumor p53, KIT, stem cell factor, PDGFR‐alpha and survival in Merkel cell carcinomaInternational Journal of Cancer, 2010
- A Phase II Trial of Imatinib Mesylate in Merkel Cell Carcinoma (Neuroendocrine Carcinoma of the Skin)American Journal of Clinical Oncology, 2010
- Merkel cell carcinoma: correlation of KIT expression with survival and evaluation of KIT gene mutational statusHuman Pathology, 2010
- Merkel Cell Polyomavirus-Infected Merkel Cell Carcinoma Cells Require Expression of Viral T AntigensJournal of Virology, 2010
- Gastrointestinal stromal tumor: a bridge between bench and bedsideGastric Cancer, 2009
- Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA relative abundance and oncogene expressionInternational Journal of Cancer, 2009
- Clonal Integration of a Polyomavirus in Human Merkel Cell CarcinomaScience, 2008
- Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivityCarcinogenesis, 2005
- Factors Associated With Disease Progression in Patients With Gastrointestinal Stromal Tumors in the Pre-Imatinib EraAmerican Journal of Clinical Pathology, 2005
- Pdgfr‐α in 1p/19q LOH oligodendrogliomasInternational Journal of Cancer, 2004